NDC 57894-640

Tremfya 100 mg per 1 mL injection

On the label: Janssen Biotech, Inc..

United States: 2Switzerland: 1Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Biogen MA Inc.Morrisville, NC, United StatesMakes the active ingredient No problems foundJun 13, 2018 · 9 inspections
Cilag AGSchaffhausen, SwitzerlandMakes it, tests it and packages it No problems foundNov 21, 2025 · 8 inspections
Janssen Biotech, Inc.Malvern, PA, United StatesMakes the active ingredient Problems found, fixed voluntarilyJul 29, 2025 · 13 inspections
Janssen Sciences Ireland UCCO Cork, IrelandMakes the active ingredient and tests it Problems found, fixed voluntarilyJan 12, 2024 · 5 inspections
AndersonBrecon Inc.Rockford, IL, United StatesPackages it No problems foundAug 19, 2026 · 11 inspections
Janssen Biologics B.V.Leiden, NetherlandsTests it Problems found, fixed voluntarilyJun 1, 2023 · 7 inspections
Janssen Pharmaceutica NVBeerse, BelgiumPackages it and labels it Problems found, fixed voluntarilySep 5, 2025 · 8 inspections
PPD Development Ireland Ltd.Athlone, IrelandTests it Problems found, fixed voluntarilyMar 9, 2023 · 4 inspections

Recalls

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug
Guselkumab: every company that makes it
Form
injection, subcutaneous
Strength
100 mg per 1 mL
Approval
BLA BLA761061
On the market since
Jul 13, 2017
Package NDCs
57894-640-01 57894-640-03 57894-640-04 57894-640-06 57894-640-11 57894-640-99
Official label
DailyMed (National Library of Medicine), updated Oct 20, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?